Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer

Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01597999

Enrollment

Registered

2012-05-15

Start date

2011-02-28

Completion date

2013-12-31

Last updated

2013-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Breast Cancer

Brief summary

This study examines the additional benefits of magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features.

Detailed description

Dedicated Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)

Interventions

RADIATIONMRI

magnetic resonance imaging (MRI) with Gadovist in early breast cancer with poor prognostic features

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with invasive ductal carcinoma * Patients undergoing DCE-MRI scan which are assessed according to BI-RADS lexicon * Breast cancer patients with pathological diagnosed invasive ductal carcinoma with hormonal receptor (ER, PR and HER-2) response * Patients who have signed on informed consent form Patients will undergo MRI imaging and the physicians will practice according to practice guidelines.

Exclusion criteria

* Patients under 18 years old or during pregnancy * Patients with MRI's contraindications e.g. patients with cardiac pacemaker or are allergic to MRI contrast agent Patients with unstable clinical abnormality and might get unexpected clinical treatment

Design outcomes

Primary

Measure	Time frame	Description
study the benefits of DCE-MRI using Gadovist in prognostic determination of early invasive breast cancer	1 year	The benefits of breast tumor diagnosis from DCE-MRI in early invasive breast cancer with poor prognostic features

Secondary

Measure	Time frame	Description
ascertain the accuracy of pre-operative DCE-MRI in terms of detection and characterization of breast cancer, as compared to tissue biopsy.	1 year	The comparision between DCE-MRI radiological features in early invasive breast cancer with poor prognostic features and early invasive breast cancer with good prognostic features To ascertain the accuracy of pre-operative DCE-MRI in terms of detection and charecterization of breast cancer, as compared to tissue biopsy

Countries

Thailand

Contacts

Primary ContactDr.Pornpim Korpraphong, Assist.Prof.

pfuang@yahoo.com6624197000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026